Cite
HARVARD Citation
Duboscq, C. et al. (2018). The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban. Journal of thrombosis and haemostasis. pp. 1626-1631. [Online].